28 Aug 20252cites
High‐Integrity Nanoformulation of Resiquimod (R848) for Dual Autophagy Activation and PD‐L1 Modulation in Triple‐Negative Breast CancerPublisher siteMacromolecular Bioscience, Nanoplatforms for cancer theranostics
Active, last published 2026
In rna interference and gene delivery
Sara Aly
Attia
Scholar“Research focused on RNA Interference and Gene Delivery and adjacent fields.”
Claim Your Profile9
H-index
346
Citations
Sara has not officially claimed their profile. If you are Sara, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ara Aly Attia is a researcher working on RNA Interference and Gene Delivery. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Sara's work has been cited 346 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
RNA Interference and Gene Delivery×10Nanoparticle-Based Drug Delivery×7Advanced biosensing and bioanalysis techniques×5Nanoplatforms for cancer theranostics×4Advanced Drug Delivery Systems×3
04 · Where I am
Affiliations
Affiliation on published researchBadr University in Cairo, EgyptDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
2 works9 Apr 2025
High-integrity nanoemulsions formulation of resiquimod (R848) enhances stability and delivery for triple negative breast cancer immunotherapyPublisher sitebioRxiv (Cold Spring Harbor Laboratory), Nanoparticle-Based Drug Delivery
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Sara?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you